Diabetes management technology pioneer Beta Bionics has achieved another milestone, successfully amassing $100 million in its latest Series D equity funding round. The recent accomplishment surpasses ...

This week, Tandem Diabetes Care’s t:slim X2 insulin pump and Control-IQ algorithm made headlines as they became the first to integrate with Dexcom’s G7 sensor to create an artificial pancreas system.

Beta Bionics, Inc. ((BBNX)) announced an update on their ongoing clinical study. Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst ...

IRVINE, Calif., March 31, 2026 (GLOBE NEWSWIRE) -- Beta Bionics today announced the launch of Bionic Insights™, an innovative new feature within its Bionic Reports, designed to help healthcare ...

Beta Bionics Inc. received U.S. FDA clearance for its Ilet Bionic Pancreas, an automated insulin-delivery (AID) system that calculates 100% of insulin doses without requiring carb counting or manual ...

I have been actively covering shares of Beta Bionics, Inc. (BBNX) since the IPO early this year, with my last take in September concluding that the company was guiding conservatively after all. Its ...